Type 2 & other diabetes

Vitamin D Receptor Polymorphisms and the Effect of Vitamin D Supplementation on Diabetes Risk Among Adults With Prediabetes

JAMA Netw OpenPublished Genetic association study

Authors' conclusion

This genetic association study of adults with prediabetes suggests that diabetes risk reduction after supplementation with 4000 IU/d of vitamin D3 was restricted to participants carrying the AC and CC alleles of the ApaI polymorphism. These findings support the potential role of ApaI genotyping in identifying individuals most likely to experience benefits from high-dose vitamin D3 treatment to reduce diabetes risk.

Study context

Population
Adults with prediabetes in the D2d trial with available intratrial 25(OH)D levels and genotyping; mean age 60.2 years, 55.7% men1,903 in discovery phase
Participants
2,098 adults
Comparison
Vitamin D3 4000 IU/d vs placebo, by ApaI genotype
Primary endpoint
Incident diabetes with vitamin D3 vs placebo according to ApaI genotypes (test phase)
Follow-up
Median 2.5 years (IQR, 1.8-3.5 years)
Methodological detailssecondary analysis of the D2d randomised trial, vitamin D receptor (VDR) genotype analysis of ApaI, BsmI and FokI polymorphisms, discovery phase and test phase analyses, D2d trial conducted October 1, 2013, to November 28, 2018; analysis January 3 to November 30, 2025
  • Secondary analysis of the D2d randomised trial
  • VDR genotype analysis of ApaI, BsmI and FokI polymorphisms
  • Discovery phase and test phase analyses
  • D2d trial conducted October 1, 2013, to November 28, 2018; analysis January 3 to November 30, 2025

Primary result

As reported in the abstract

Incident diabetes by ApaI genotype
Vitamin D3 vs PlaceboHazard ratio (95% CI)
ApaI AA (n=618): no response
1.02(0.72–1.44)
ApaI AC and CC (n=1480): 19% decrease in risk
0.81(0.66–0.99)

Original publication

Vitamin D Receptor Polymorphisms and the Effect of Vitamin D Supplementation on Diabetes Risk Among Adults With Prediabetes. JAMA Netw Open. Published 1 April 2026. doi:10.1001/jamanetworkopen.2026.7332

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.